Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation for Acute Pneumonia in Tanzanian Children
NCT00133432Phase 3Terminated
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pneumonia (PNA) comparing Zinc Group with Placebo Group (2 arms). Primary endpoint: Duration of hospitalization. Started Sep 2005; status: terminated.
02
Drugs
zinc
03
Conditions
pneumonia (PNA)
Beyond the preview
Go deeper on NCT00133432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133432.